| 215515 | NDA | ALNYLAM PHARMS INC | | 001 | AMVUTTRA | SOLUTION;SUBCUTANEOUS | EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) | VUTRISIRAN SODIUM | 2022-06-13 | Prescription | Yes |
| 214103 | NDA | ALNYLAM PHARMS INC | | 001 | OXLUMO | SOLUTION;SUBCUTANEOUS | EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML) | LUMASIRAN SODIUM | 2020-11-23 | Prescription | Yes |
| 212194 | NDA | ALNYLAM PHARMS INC | | 001 | GIVLAARI | SOLUTION;SUBCUTANEOUS | EQ 189MG BASE/ML (EQ 189MG BASE/ML) | GIVOSIRAN SODIUM | 2019-11-20 | Prescription | Yes |
| 210922 | NDA | ALNYLAM PHARMS INC | | 001 | ONPATTRO | SOLUTION;INTRAVENOUS | EQ 10MG BASE/5ML (EQ 2MG BASE/ML) | PATISIRAN SODIUM | 2018-08-10 | Prescription | Yes |